Common Contracts
1 similar null contracts
Lonza enters development and manufacturing agreement with Genmab A/S for a novel antibody drug conjugate (ADC), HuMax-TF™October 25th, 2011
This agreement secures a development and cGMP manufacturing plan for Genmab A/S, a biotechnology company engaged in the development of human antibody therapeutics for the potential treatment of cancer
